Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared Anna Wolska‘s post on LinkedIn:
“This is a really insightful open-access editorial commentary by one of Poland’s gifts to Lipidology:
Anna W. and the Lipid Lab Director at NIH is not for novices but we do need to better understand the genome or lipid and lipoprotein interactions message is so true.
Whatever expertise I have in lipids is because of the many smart folks I have been lucky to hang around and learn from over the years.
Congrats to my two friends”
Anna Wolska, Editorial Board Member of Lipids in Health and Disease journal at Springer Nature Technology and Publishing Solutions, Associate Scientist at National Heart, Lung, and Blood Institute, shared a post on LinkedIn about a recent article she and Alan T. Remaley co-authored, published in JACC: Case Reports, adding:
“Pleased to share our new Editorial Comment in JACC: Case Reports, co-authored with Alan T. Remaley, accompanying an interesting case of familial hypercholesterolemia and sitosterolemia occurring together.
A fascinating example of how functional genomics can reveal the biology behind an unexpected treatment response—and inform precision lipidology.”
Title: When Lipid-Lowering Therapy Fails: Lessons From Functional Genomics and Precision Lipidology
Authors: Anna Wolska, Alan T. Remaley
Other posts featuring Thomas Dayspring on Hemostasis Today.
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line
-
Sep 19, 2026, 01:28Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points
-
Sep 19, 2026, 01:23Chokri Ben Lamine: Cemdisiran in PNH – Why Combine Complement Therapies?